Staibano Stefania, Ilardi Gennaro, Leone Vincenza, Luise Chiara, Merolla Francesco, Esposito Francesco, Morra Francesco, Siano Maria, Franco Renato, Fusco Alfredo, Chieffi Paolo, Celetti Angela
Istituto di Endocrinologia ed Oncologia Sperimentale, CNRz, via S Pansini, 5, Naples 80131, Italy.
BMC Cancer. 2013 Sep 24;13:433. doi: 10.1186/1471-2407-13-433.
DNA damage response has been clearly described as an anti-cancer barrier in early human tumorigenesis. Moreover, interestingly, testicular germ cell tumors (TGCTs) have been reported to lack the DNA Damage Response (DDR) pathway activation. CCDC6 is a pro-apoptotic phosphoprotein substrate of the kinase ataxia telangectasia mutated (ATM) able to sustain DNA damage checkpoint in response to genotoxic stress and is commonly rearranged in malignancies upon fusion with different partners. In our study we sought to determine whether CCDC6 could have a role in the patho-genesis of testicular germ cell tumors.
To achieve this aim, analysis for CCDC6 expression has been evaluated on serial sections of the mouse testis by immunohistochemistry and on separate populations of murine testicular cells by western blot. Next, the resistance to DNA damage-induced apoptosis and the production of reactive oxygen species has been investigated in GC1 cells, derived from immortalized type B murine germ cells, following CCDC6 silencing. Finally, the CCDC6 expression in normal human testicular cells, in Intratubular Germ Cell Neoplasia Unclassified (IGCNU), in a large series of male germ cell tumours and in the unique human seminoma TCam2 cell line has been evaluated by immunohistochemistry and by Western Blot analyses.
The analysis of the CCDC6 expression revealed its presence in Sertoli cells and in spermatogonial cells. CCDC6 loss was the most consistent feature among the primary tumours and TCam2 cells. Interestingly, following treatment with low doses of H₂O₂, the silencing of CCDC6 in GC1 cells caused a decrease in the oxidized form of cytochrome c and low detection of Bad, PARP-1 and Caspase 3 proteins. Moreover, in the silenced cells, upon oxidative damage, the cell viability was protected, the γH2AX activation was impaired and the Reactive Oxygen Species (ROS) release was decreased.
Therefore, our results suggest that the loss of CCDC6 could aid the spermatogonial cells to be part of a pro-survival pathway that helps to evade the toxic effects of endogenous oxidants and contributes to testicular neoplastic growth.
DNA损伤反应已被明确描述为人类早期肿瘤发生过程中的一种抗癌屏障。此外,有趣的是,据报道睾丸生殖细胞肿瘤(TGCTs)缺乏DNA损伤反应(DDR)途径的激活。CCDC6是共济失调毛细血管扩张突变激酶(ATM)的一种促凋亡磷蛋白底物,能够在基因毒性应激下维持DNA损伤检查点,并且在与不同伙伴融合后通常在恶性肿瘤中发生重排。在我们的研究中,我们试图确定CCDC6是否在睾丸生殖细胞肿瘤的发病机制中发挥作用。
为实现这一目标,通过免疫组织化学在小鼠睾丸连续切片上以及通过蛋白质印迹在小鼠睾丸细胞的不同群体中评估CCDC6的表达。接下来,在CCDC6沉默后,研究了源自永生化B型小鼠生殖细胞的GC1细胞对DNA损伤诱导的凋亡的抗性和活性氧的产生。最后,通过免疫组织化学和蛋白质印迹分析评估了正常人类睾丸细胞、未分类的管内生殖细胞瘤(IGCNU)、大量男性生殖细胞肿瘤以及独特的人类精原细胞瘤TCam2细胞系中CCDC6的表达。
CCDC6表达分析显示其存在于支持细胞和精原细胞中。CCDC6缺失是原发性肿瘤和TCam2细胞中最一致的特征。有趣的是,在用低剂量H₂O₂处理后,GC1细胞中CCDC6的沉默导致细胞色素c氧化形式的减少以及Bad、PARP - 1和Caspase 3蛋白的低检测水平。此外,在沉默细胞中,氧化损伤后细胞活力得到保护,γH2AX激活受损,活性氧(ROS)释放减少。
因此,我们的结果表明CCDC6的缺失可能有助于精原细胞成为促生存途径的一部分,该途径有助于逃避内源性氧化剂的毒性作用并促进睾丸肿瘤生长。